On 8/6/24, Pediatrix Medical Group Inc (NYSE: MD) stock enjoyed a major increase of 17.7%, closing at $8.97. NORMAL trading volume accompanied the advance. Relative to the market the stock has been weak over the last nine months but has risen 9.3% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be above the cost of capital, MD is expected to continue to be an important Value Builder.
Pediatrix Medical Group has a current Value Trend Rating of D (Negative). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Pediatrix Medical Group has a slightly positive Appreciation Score of 65 but a very low Power Rating of 6, producing the Negative Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment